Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

Acute myeloid leukemia carries a dismal prognosis in older patients. The objective of this study was to investigate the safety and efficacy of decitabine combined with the CXCR4 antagonist plerixafor in newly diagnosed older patients with acute myeloid leukemia and to evaluate the effects of plerixa...

Descripción completa

Detalles Bibliográficos
Autores principales: Roboz, Gail J., Ritchie, Ellen K., Dault, Yulia, Lam, Linda, Marshall, Danielle C., Cruz, Nicole M., Hsu, Hsiao-Ting C., Hassane, Duane C., Christos, Paul J., Ippoliti, Cindy, Scandura, Joseph M., Guzman, Monica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068018/
https://www.ncbi.nlm.nih.gov/pubmed/29724902
http://dx.doi.org/10.3324/haematol.2017.183418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068018/
https://www.ncbi.nlm.nih.gov/pubmed/29724902
http://dx.doi.org/10.3324/haematol.2017.183418

Ejemplares similares